GlassScriptPhysician profile
Johnny Steven Su
NPI 1558949768
$7,612.27
in general payments reported to CMS, 2019-2025
24 companies · $2,274 in 2025
The $2,274 reported for 2025 was more than what 82% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $149 · 2022: $1,344 · 2023: $1,941 · 2024: $1,904 · 2025: $2,274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,119.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,107.83 | 2021-2025 | Interstim |
| Biotissue Holdings INC. | $1,199.80 | 2023-2025 | |
| Boston Scientific Corporation | $1,080.31 | 2022-2025 | Ams 700, Axonics, Lithovue |
| Procept Biorobotics Corporation | $610.38 | 2022-2025 | Aquabeam Robotic System |
| Baxter Healthcare | $509.26 | 2023-2025 | Tisseel, Perclot |
| Medical Device Business Services, INC. | $322.70 | 2022 | |
| Sumitomo Pharma America, INC. | $310.68 | 2023-2025 | Gemtesa, Orgovyx |
| Abbvie INC. | $261.90 | 2022-2025 | Botox |
| Urogen Pharma, INC. | $168.07 | 2023 | Jelmyto |
| Coloplast Corp | $151.16 | 2023 | Titan |
| Bluewind Medical | $147.65 | 2024 | Revi |
| Axonics, INC. | $127.25 | 2023-2024 | Axonics |
| Myriad Genetic Laboratories, INC. | $124.14 | 2024 | Prolaris |
| Janssen Biotech, INC. | $122.53 | 2022 | |
| Edap Technomed INC | $117.89 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $62.16 | 2022-2023 | Keytruda |
| Progenics Pharmaceuticals, INC. | $31.74 | 2022 | |
| Photocure INC | $27.59 | 2023 | Cysview |
| Ambu INC. | $27.27 | 2025 | |
| Novo Nordisk INC | $24.16 | 2024 | Rivfloza |
| Pacira Pharmaceuticals Incorporated | $22.57 | 2024 | Exparel |
| Teleflex LLC | $19.88 | 2022 | |
| Telix Pharmaceuticals | $18.54 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johnny Su listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.